A Research Platform to Screen Healthcare Workers- Coordinated Approach to Pandemic Trials of COVID-19 Read more about A Research Platform to Screen Healthcare Workers- Coordinated Approach to Pandemic Trials of COVID-19
On Target Laboratories, Inc. By efain on Wed, 09/16/2020 - 16:07 Read more about On Target Laboratories, Inc. Expanded Access Listings BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency Conditions Limbal Stem Cell Deficiency (LSCD) The goal of this program is to provide patients with Limbal Stem Cell Deficiency accessto the BRM421 eye drops.Participants will: - Use BRM421 two times a day for at least 12 weeks - Visit the clinic monthly for checkups and tests
Kazia Therapeutics Limited By efain on Thu, 09/03/2020 - 11:44 Read more about Kazia Therapeutics Limited
